Fri, March 31, 2023
Thu, March 30, 2023
Wed, March 29, 2023
Tue, March 28, 2023
Mon, March 27, 2023
Fri, March 24, 2023

Danielle Antalffy Initiated (TNDM) at Hold and Held Target at $45 on, Mar 29th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-45-on-mar-29th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Danielle Antalffy of UBS, Initiated "Tandem Diabetes Care, Inc." (TNDM) at Hold and Held Target at $45 on, Mar 29th, 2023.

Danielle has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 2 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $40 on, Thursday, February 23rd, 2023
  • Mike Polark of "Wolfe Research" Initiated at Hold on, Thursday, January 26th, 2023


These are the ratings of the 3 analyists that currently disagree with Danielle


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $47 on, Friday, February 24th, 2023
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $52 on, Thursday, February 23rd, 2023
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $50 on, Thursday, February 23rd, 2023

Publication Contributing Sources